CCM
ANIP icon

Consonance Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Consonance Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-142,943
Closed -$10.4M – 37
2019
Q3 		$10.4M Hold
142,943
– – 1.03% 23
2019
Q2 		$11.8M Hold
142,943
– – 0.83% 25
2019
Q1 		$10.1M Hold
142,943
– – 0.64% 24
2018
Q4 		$6.43M Hold
142,943
– – 0.47% 23
2018
Q3 		$8.08M Hold
142,943
– – 0.44% 29
2018
Q2 		$9.55M Hold
142,943
– – 0.62% 28
2018
Q1 		$8.32M Sell
142,943
-35
-0% -$2.22K 0.76% 23
2017
Q4 		$9.21M Sell
142,978
-25
-0% -$1.55K 0.83% 20
2017
Q3 		$7.51M Hold
143,003
– – 0.83% 16
2017
Q2 		$6.69M Hold
143,003
– – 0.79% 16
2017
Q1 		$7.08M Sell
143,003
-348,605
-71% -$19.6M 0.74% 20
2016
Q4 		$29.8M Sell
491,608
-161,650
-25% -$9.88M 3.27% 14
2016
Q3 		$43.3M Sell
653,258
-164,198
-20% -$10.3M 4.17% 11
2016
Q2 		$45.6M Sell
817,456
-210,908
-21% -$10.3M 6.46% 7
2016
Q1 		$34.6M Buy
1,028,364
+81,875
+9% +$2.78M 5.24% 12
2015
Q4 		$42.7M Sell
946,489
-109,800
-10% -$4.73M 5.73% 10
2015
Q3 		$41.7M Buy
1,056,289
+498
+0% +$28.3K 5.87% 7
2015
Q2 		$65.5M Sell
1,055,791
-68,876
-6% -$4.1M 6.58% 7
2015
Q1 		$70.3M Buy
1,124,667
+34,600
+3% +$2.1M 6.41% 7
2014
Q4 		$61.5M Buy
1,090,067
+540,240
+98% +$23.8M 7.92% 4
2014
Q3 		$15.5M Buy
549,827
+194,551
+55% +$5.83M 2.13% 16
2014
Q2 		$12.2M Buy
355,276
+104,013
+41% +$3.26M 1.82% 21
2014
Q1 		$7.88M Buy
+251,263
New +$6.67M 1.17% 24

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Consonance Capital Management's ANIP Position: Q4 2019 in Review

Consonance Capital Management sold out of ANI Pharmaceuticals (ANIP) in Q4 2019, closing a stake of 142,943 shares — an estimated $10.4M sold.

Consonance Capital Management first reported a position in ANIP in Q1 2014 and held it in 23 quarters. The position peaked at $70.3M in Q1 2015. 170 funds tracked by Wall St. Rank hold ANIP as of Q4 2019.

  • Consonance Capital Management reported no remaining ANI Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Consonance Capital Management sold 142,943 ANI Pharmaceuticals shares in Q4 2019, an estimated $10.4M.
  • Consonance Capital Management first reported a position in ANI Pharmaceuticals in Q1 2014 and held it in 23 quarters.
  • Consonance Capital Management's ANI Pharmaceuticals position peaked at $70.3M in Q1 2015.
  • 170 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2019.

Based on Consonance Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.